Early research (Phase 1)Study completedNCT00905346What this trial is testingTopiramate 25 mg Capsule Mixed With Applesauce Under Fasting ConditionsWho this might be right forHealthy Teva Pharmaceuticals USA 24
Large-scale testing (Phase 3)Study completedNCT01191086What this trial is testingOpen-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset SeizuresWho this might be right forEpilepsy Upsher-Smith Laboratories 210
Testing effectiveness (Phase 2)Study completedNCT00236860What this trial is testingThe Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset SeizuresWho this might be right forEpilepsyEpilepsies, PartialSeizures Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 56
Large-scale testing (Phase 3)Study completedNCT00231530What this trial is testingThe Safety and Efficacy of Topiramate in the Treatment of Obese, Type 2 Diabetes Patients on a Controlled DietWho this might be right forObesityDiabetes Mellitus, Type 2Diabetes Mellitus, Adult-Onset Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 541
Testing effectiveness (Phase 2)Ended earlyNCT01789047What this trial is testingTopiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's DiseaseWho this might be right forIdiopathic Parkinson's DiseaseDrug Induced Dyskinesia Rush University Medical Center 42
Post-approval studies (Phase 4)UnknownNCT04453306What this trial is testingTreatment of Obesity With Topiramate in Patients With Polycystic Ovary SyndromeWho this might be right forObesityPolycystic Ovary SyndromeHyperandrogenism Hospital de Clinicas de Porto Alegre 80
Post-approval studies (Phase 4)Study completedNCT00203463What this trial is testingTopiramate in the Treatment of Post Traumatic Stress Disorder (PTSD)Who this might be right forPTSD Tuscaloosa Research & Education Advancement Corporation 40
Large-scale testing (Phase 3)Study completedNCT00563368What this trial is testingA Study Comparing Multiple Doses of VI-0521 With Placebo and Their Single-agent Constituents for Treatment of Obesity in AdultsWho this might be right forObesity VIVUS LLC 756
Large-scale testing (Phase 3)UnknownNCT03479086What this trial is testingDefining the Clinical Role of Topiramate in the Treatment of Alcohol Dependence in AustraliaWho this might be right forAlcohol Dependence South West Sydney Local Health District 180
Large-scale testing (Phase 3)Study completedNCT00236886What this trial is testingProspective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy PatientsWho this might be right forEpilepsyEpilepsies, PartialEpilepsy, Generalized+1 more Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 49
Large-scale testing (Phase 3)Ended earlyNCT00563459What this trial is testingCarisbamate Retention Study (CaReS): Comparative Study on the Long Term Effectiveness, Safety and Tolerability of Carisbamate Compared to Two Other Frequently Prescribed Anti-epileptic Drugs (AEDs) in Patients With Epilepsy.Who this might be right forEpilepsySeizures SK Life Science, Inc. 89
Large-scale testing (Phase 3)Study completedNCT00210912What this trial is testingThe Effectiveness and Safety of Topiramate Versus Placebo for Preventing Chronic Migraine HeadachesWho this might be right forMigraine Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 328
Post-approval studies (Phase 4)Study completedNCT00210496What this trial is testingPotential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of MigraineWho this might be right forMigraineClassic MigraineCommon Migraine Janssen-Ortho LLC 406
Testing effectiveness (Phase 2)Study completedNCT01799590What this trial is testingContinuous Treatment Study of Topiramate in Migraine ParticipantsWho this might be right forMigraine Janssen Pharmaceutical K.K. 296
Post-approval studies (Phase 4)Study completedNCT04408586What this trial is testingAnti-Obesity Phentermine-Topiramate Extended Release Pharmacotherapy vs Placebo Among Patients Using a Wearable Activity TrackerWho this might be right forObesity Mayo Clinic 80
Post-approval studies (Phase 4)Study completedNCT00200941What this trial is testingEfficacy and Safety Study of Topiramate to Treat Restless Legs SyndromeWho this might be right forRestless Legs Syndrome Neurocare 44
Large-scale testing (Phase 3)Study completedNCT00236665What this trial is testingEfficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential HypertensionWho this might be right forObesityHypertension Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 531
Not applicableWithdrawnNCT01970566What this trial is testingComparison of the Effect of Intense-Exercise/Moderate-Calorie, Topiramate-Phentermine and Cognitive Behavioral Therapy on ObesityWho this might be right forObesityDiabetes Mellitus US Department of Veterans Affairs
Large-scale testing (Phase 3)WithdrawnNCT00463775What this trial is testingTopiramate for Treatment of Patients With Borderline Personality Disorder and Alcohol DependenceWho this might be right forAlcohol DependenceBorderline Personality Disorder Elizabeth Ralevski
Post-approval studies (Phase 4)Study completedNCT00550394What this trial is testingEfficacy and Tolerability of Topiramate in Treatment of Bipolar Mania and Alcohol Use in Adolescents and Young AdultsWho this might be right forBipolar DisorderAlcohol Abuse University of Cincinnati 56